GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 38.46 percent. This is a 52.94 percent increase over losses of $(0.34) per share from the same period last year.
Here’s Why XPeng (XPEV) Stock Is Moving
XPeng Inc - ADR (NYSE: XPEV) shares are trading lower by 1.41% to $16.05 Monday morning.